Atom

Walmart Labs acquires two Bengaluru-based startups FloCare and BigTrade

Written by : IANS

Walmart Labs, the technology arm of US retail giant Walmart, has acquired two Bengaluru-based startups - FloCare and BigTrade - for an undisclosed sum.

Founded by former Google employees, FloCare is a health-tech company that organises all the work a clinician needs to do in one place and aims to make "ageing at home" more affordable and scalable. A startup funded by Accel Partners, FloCare platform offers healthcare services to help make ageing at home more affordable and scalable.

BigTrade offers a wholesale trading platform which provides an "end-to-end" business solution from the discovery of the product or supplier to payment of the product. 

While FloCare, which also has an office in California's Palo Alto, has joined Walmart Labs' customer technology team, BigTrade became part of the organisation's supply chain team. 

According to a Mint report, BigTrade founder Sunil Soni has joined Walmart Labs as an architect and will work on network optimizations and forecasting solutions for warehouse management. Kiran Lingam, other founder has joined as the product manager in the supply chain team and will be responsible for building the next generation of warehousing and transportation solutions for the company.

"We are in an exciting phase of transformation and it feels great to add terrific minds from the start-up ecosystem in India to our growing team," Hari Vasudev, Center Head & Vice President - Technology, Walmart Labs India, said in a statement on Tuesday. 

"Walmart's online pharmacy and supply chain business are renowned across the globe and I am sure the FloCare and BigTrade teams will strengthen our capabilities as we strive to build awesome omnichannel customer experiences around the globe," Vasudev said.

Being KC Venugopal: Rahul Gandhi's trusted lieutenant

SC rejects pleas for 100% verification of VVPAT slips

Mallikarjun Kharge’s Ism: An Ambedkarite manifesto for the Modi years

Political battles and opportunism: The trajectory of Shobha Karandlaje

Rajeev Chandrasekhar's affidavits: The riddle of wealth disclosure